U.S. Army USAMRAA accepts applications for DoW Duchenne Muscular Dystrophy Clinical/Translational Award
Grants
Copyright © Targeted News Service, 2026
Copyright © Targeted News Service, 2026
2026-06-18
Bailey Malota
WASHINGTON, June 18 -- The U.S. Army, through its USAMRAA, has announced the opening of applications for the DoW Duchenne Muscular Dystrophy Clinical/Translational Award. This competitive grant aims to support innovative research focused on Duchenne Muscular Dystrophy (DMD), a severe genetic disorder characterized by progressive muscle degeneration. The DoW award encourages applications that aim to advance understanding of DMD and enhance therapeutic strategies. Proposed projects may encompass a . . .
TARGETED NEWS SERVICE (founded 2004) features non-partisan 'edited journalism' news briefs and information for news organizations, public policy groups and other organizations. For more information contact MYRON STRUCK, editor, editor@targetednews.com, Springfield, Virginia; 703/304-1897; https://targetednews.com
WASHINGTON, June 18 -- The U.S. Army, through its USAMRAA, has announced the opening of applications for the DoW Duchenne Muscular Dystrophy Clinical/Translational Award. This competitive grant aims to support innovative research focused on Duchenne Muscular Dystrophy (DMD), a severe genetic disorder characterized by progressive muscle degeneration. The DoW award encourages applications that aim to advance understanding of DMD and enhance therapeutic strategies. Proposed projects may encompass a . . .
To gain access to full content fill out the form below.
Information Request Form
TARGETED NEWS SERVICE (founded 2004) features non-partisan 'edited journalism' news briefs and information for news organizations, public policy groups and other organizations. For more information contact MYRON STRUCK, editor, editor@targetednews.com, Springfield, Virginia; 703/304-1897; https://targetednews.com
